张芃

中国医学科学院阜外医院 普外科

[Mid-term results of surgical treatment for aortic regurgitation with large left ventricle].

OBJECTIVE:To evaluate the recent and mid-term results of aortic valve replacement for aortic valve insufficiency with large left ventricle.METHODS:From Dec 1999 to Jan 2006, 31 patients with aorta insufficiency with the left ventricle larger than 80 mm, 30 males and 1 female, aged (36 -/+ 11), underwent aortic valve replacement and were followed up after discharge by mail and/or telephone call for (46 +/- 23) months (3-85 months), and followed up by ultrasonography for (25 +/- 24) months (3-70 months). The ultrasound cardiographic data were analyzed. Groups were divided according to heart function and LVED to analyze risk factors after operation.RESULTS:One case died before discharge from the hospital and 3 cases died during the follow-up. The left ventricular end-diastolic diameter (LVEDD) after operation was (69 +/- 11) mm, significantly smaller than that before operation [(86 +/- 8) mm, P = 0.001]. The LVEDD continued to decrease during the follow-up and became (55 +/- 10) mm. The ejection fraction early during the follow-up was (58 +/- 15), significantly higher than that before operation [(48 +/- 13)%, P = 0.001]. The heart function and LVEDD before operation had little effects on the long term mortality and left ventricle function. Conclusion The patients with aortic valve insufficiency and large left ventricle still have indication for surgical treatment and most of such patients have good results in mid-term follow-up.

Zhonghua yi xue za zhi 2008

[Plasmid transfection of rat bone marrow mesenchymal stem cells by cationic lipid for gene-modified cell transplantation therapy].

OBJECTIVE:To investigate the feasibility of gene transfection of bone marrow mesenchymal stem cell (BMSC) by cationic lipid.METHODS:The relative optimal transfection condition was determined by scale transfection experiment in vitro and the transient transfection efficiency of enhanced green fluorescence protein (EGFP) gene for rat BMSC was determined with Lipofectamine2000 (LP2000). The relationship between cell cycle status and the expression of the gene was analyzed. The intensity and the ratio of EGFP gene expression versus time was determined by flow cytometry. In the in vivo study, the transgenic rat BMSC was injected into the myocardium of inbred rats, and the in vivo transcription of EGFP gene and the EGFP-expressing BMSC were traced in the myocardium after transplantation using reverse transcription-polymerase chain reaction and fluorescent microscopy, respectively.RESULTS:EGFP gene transfection efficiency in BMSC was different under different transfection condition (DNA concentration and DNA: LP2000). Cationic lipid-mediated transfection demonstrated marked toxicity to BMSC. Cell cycle status restricted the expression efficiency of the gene introduced by cationic lipid. The EGFP expressing-BMSC and in vivo transcription of the EGFP gene could be detected in rat myocardium post implantation.CONCLUSION:Cationic lipid is an effective carrier for gene-modified cell transplantation therapy.

第一作者

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2005